10 Years of pressurized intraperitoneal aerosol chemotherapy (PIPAC): a systematic review and meta-analysis

A Di Giorgio, A Macrì, F Ferracci, M Robella… - Cancers, 2023 - mdpi.com
Simple Summary In recent years, pressurized intraperitoneal aerosol chemotherapy (PIPAC)
has emerged as a feasible method of intraperitoneal drug administration in patients affected …

Pressurized intraperitoneal aerosol chemotherapy (PIPAC): updated systematic review using the IDEAL framework

AE Baggaley, GBRC Lafaurie, SJ Tate… - British Journal of …, 2023 - academic.oup.com
Methods This systematic review was conducted with the MEDLINE and Embase databases,
up to 28 February 2022. Included studies were assigned a stage (0, 1, 2a, 2b, 3, or 4), using …

[HTML][HTML] Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in patients with ovarian cancer: a systematic review

C Taliento, S Restaino, G Scutiero, M Arcieri… - European Journal of …, 2023 - Elsevier
Background PIPAC consists in delivering normothermic chemotherapy solution directly into
the peritoneal cavity as an aerosol under pressure. Currently PIPAC is considered as a …

Response evaluation in patients with peritoneal metastasis treated with pressurized IntraPeritoneal aerosol chemotherapy (PIPAC)

S Roensholdt, S Detlefsen, MB Mortensen… - Journal of Clinical …, 2023 - mdpi.com
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) directed therapy emerged as a
treatment of peritoneal metastasis (PM) a decade ago. The response assessment of PIPAC …

Patient-reported outcomes during repetitive oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for isolated unresectable colorectal peritoneal …

RJ Lurvink, KP Rovers, ECE Wassenaar, C Bakkers… - Surgical …, 2022 - Springer
Background CRC-PIPAC prospectively assessed repetitive oxaliplatin-based pressurized
intraperitoneal aerosol chemotherapy (PIPAC-OX) as a palliative monotherapy (ie, without …

Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in a Refractory Colorectal and Appendiceal Carcinomatosis: Secondary Analysis of the …

MT Waheed, N Ruel, RL Whelan, M Fakih… - Annals of Surgical …, 2024 - Springer
Background Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) is a novel,
minimally invasive, safe, and repeatable method to treat carcinomatosis. Evidence regarding …

腹膜转移癌腹腔化疗的创新与挑战

冯欣滢, 王冰, 刘培峰 - 中国癌症杂志, 2024 - china-oncology.com
腹膜转移癌是指从原发部位扩散至腹膜的恶性肿瘤, 常见于胃癌, 结直肠癌,
卵巢癌及腹膜假黏液瘤(pseudomyxoma peritonei, PMP) 等多种癌症类型的晚期阶段 …

Innovations and challenges in intraperitoneal chemotherapy for peritoneal metastatic carcinoma

F Xinying, W Bing, LIU Peifeng - China Oncology, 2024 - china-oncology.com
Peritoneal metastatic carcinoma refers to the spread of malignant tumors from the primary
site to the peritoneum. It is commonly observed in the advanced stages of various cancer …

[PDF][PDF] ORCA–Online Research@ Cardiff

AE Baggaley, GBRC Lafaurie, SJ Tate, PR Boshier… - 2022 - core.ac.uk
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a surgical innovation
deployed to treat peritoneal metastases. Traditionally, peritoneal metastases have been …